Sponsor

ResMed

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name ResMed appears in 53 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials53
Recruiting shown1
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

53 shown
Leo Study Unstable AsthmaNCT05308277 · lead sponsor · 2022-04-27
UNKNOWN
Safety and Feasibility of a Novel Device for Assessing Respiratory Function in ChildrenNCT04873193 · lead sponsor · 2021-07-01
COMPLETED
Evaluation of a Portable Oxygen Concentrator During Ambulation for Patients Who Require Supplemental Oxygen (POC-LEAN)NCT04107493 · lead sponsor · 2019-11-21
COMPLETED
Portable Oxygen Concentrator Improvements to Physical Activity, Oxygen Usage, and Quality of Life in Chronic Obstructive Pulmonary Disease Patients Using Long-term Oxygen Therapy (POC-STEP)NCT03513068 · lead sponsor · 2018-07-24
TERMINATED
Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility StudyNCT03195660 · lead sponsor · 2017-06-26
TERMINATED
Respiration Rate Monitoring in COPD PatientsNCT03030313 · lead sponsor · 2016-12-01
COMPLETED
HomeVent ( Connect) Registry: EU COPD Home NIV RegistryNCT02811588 · lead sponsor · 2016-07-01
COMPLETED
French Cohort Study of Chronic Heart Failure Patients With Central Sleep Apnoea Eligible for Adaptive Servo-Ventilation (PaceWave, AutoSet CS, AirCurve 10CS): Predictive Factors of Poor Compliance (FACE)NCT02356367 · lead sponsor · 2016-05-01
WITHDRAWN
Positive Airway Pressure Therapy Study in Sleep Apnea and Diastolic Heart FailureNCT02254382 · lead sponsor · 2016-03-01
TERMINATED
Reassure Remote Respiration Monitoring in Heart Failure PatientsNCT02624739 · lead sponsor · 2015-12-01
TERMINATED
A Study of Expiratory Pressure Modulation in Moderate to Severe COPD Patients - Phase 1bNCT02585752 · lead sponsor · 2015-10-01
TERMINATED
Juno Perth Clinical TrialNCT02317042 · lead sponsor · 2015-05-29
TERMINATED
European Home Mechanical Ventilation RegistryNCT02315339 · lead sponsor · 2014-08-01
TERMINATED
Pilot Study Evaluating Feasibility and Benefits of Telemonitored NIV Treatment on COPD PatientsNCT02258191 · lead sponsor · 2014-07-01
COMPLETED
SchlaHF-XT-Register. Sleep Disordered Breathing in Heart Failure RegisterNCT02301689 · lead sponsor · 2014-05-01
COMPLETED
Adaptive Servo-ventilation Monitoring StudyNCT02133859 · lead sponsor · 2014-05-01
COMPLETED
The Effect of NIV on QoL and Exercise Capacity in a COPD Exercise Rehabilitation ProgramNCT02100709 · lead sponsor · 2014-04-01
TERMINATED
Cardiovascular Improvements With MV ASV Therapy in Heart FailureNCT01953874 · lead sponsor · 2013-12-01
TERMINATED
Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilationNCT01164592 · lead sponsor · 2012-08-01
COMPLETED
Ventilator Monitoring in Early Exacerbation DetectionNCT01644162 · lead sponsor · 2012-07-01
COMPLETED
Autotitrating Versus Standard Non-invasive Ventilation (NIV) in Acute Exacerbation of Respiratory FailureNCT01174316 · lead sponsor · 2010-08-01
WITHDRAWN
French Cohort Study of Chronic Heart Failure Patients With Central Sleep Apnoea Eligible for Adaptive Servo-Ventilation (PaceWave, AutoSet CS)NCT01831128 · lead sponsor · 2009-11-01
COMPLETED
Mechanisms of Action of Adaptive ServoventilationNCT00976417 · lead sponsor · 2009-09-01
COMPLETED
Treatment of Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart FailureNCT00733343 · lead sponsor · 2008-02-01
COMPLETED
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-RegistryNCT01500759 · lead sponsor · 2007-11-01
COMPLETED
Evaluation of a Portable Device for Assessing Sleep Disordered Breathing in Congestive Heart FailureNCT00493948 · lead sponsor · 2007-07-01
COMPLETED
GLYCOSA Study:Effect of PAP Treatment on Glycemic Control in Patients With Type 2 DiabetesNCT00509223 · lead sponsor · 2007-07-01
COMPLETED
Cardiovascular Responses in Congestive Heart Failure With Cheyne- Stokes RespirationNCT00495196 · lead sponsor · 2007-06-01
COMPLETED
Investigation of Heart Failure Status Over Time Using Respiratory ParametersNCT00494117 · lead sponsor · 2007-06-01
COMPLETED
Effect of HIgh-flow Therapy in Long-term Oxygen TherapyNCT06247397 · collaborator · 2024-06-10
RECRUITING
NHFT Effects on Symptatheic Drive of Asthma PatientsNCT05704101 · collaborator · 2023-07-01
COMPLETED
NIV for COPD: Hospital to HomeNCT04413643 · collaborator · 2019-05-09
TERMINATED
TELE-monitoring in Chronic Obstructive Pulmonary DiseaseNCT03129477 · collaborator · 2019-01-01
UNKNOWN
An Exploratory, Observational, Non-interventional, Open Label, Remote Pilot Study to Assess Adherence in COPD SubjectsNCT03745547 · collaborator · 2018-11-20
COMPLETED
Benefit of Cheyne-Stokes Respiration Remote Monitoring in CPAP-treated Patients With Obstructive Sleep Apnea to Detect Early Events of Heart Failure.NCT03592108 · collaborator · 2018-07-30
COMPLETED
Innovation in NOn Invasive Ventilation in COPD Patients Treated by Long Term Oxygen TherapyNCT03584269 · collaborator · 2018-06-28
TERMINATED
Obstructive Sleep Apnea, CPAP Treatment & Cognitive Ability in HIVNCT03478137 · collaborator · 2017-06-05
UNKNOWN
Phenotypic Measurements and Their Relation to Disease Exacerbation in COPD PatientsNCT03300739 · collaborator · 2016-12-01
COMPLETED
Effects of Different Oxygen Devices in Hypoxemic COPD PatientsNCT02998515 · collaborator · 2016-12-01
COMPLETED
Development of Scalable New Model(s) Focused on Care Co-ordination and Care Provision for Medically Complex, Co-morbid Chronic Disease Patient Segments Focusing on Heart FailureNCT02921607 · collaborator · 2016-09-01
COMPLETED
The Effect of Non-invasive Ventilation on the Oxygenation of Peripheral Muscle in Hypercapnic COPD PatientsNCT02877290 · collaborator · 2016-08-01
COMPLETED
Prevalence of Obstructive Sleep Apnea Syndrome in Type 1 Diabetic Patients Treated With Insulin Pump (At1Home)NCT02796534 · collaborator · 2016-07-28
COMPLETED
Long-term Cardiovascular Outcomes in Patients With RH and OSA With or Without Treatment With CPAPNCT03002558 · collaborator · 2016-04-29
COMPLETED
Intelligent Volume Assured Pressure Support to Improve Sleep Quality and Respiratory Events in Patients With Non Invasive VentilationNCT01986413 · collaborator · 2013-07-01
COMPLETED
Adaptive Servo Ventilation (ASV) in Heart FailureNCT02440971 · collaborator · 2013-05-01
SUSPENDED
Effect of Sleep Apnea Treatment on Type 1 DiabetesNCT02316665 · collaborator · 2013-04-01
COMPLETED
Target Volume in Noninvasive Positive Pressure VentilationNCT01748656 · collaborator · 2013-01-01
COMPLETED
Consequences of Obstructive Sleep Apnea on Respiratory Function Following Weight-loss SurgeryNCT01697878 · collaborator · 2012-03-01
COMPLETED
Effects of Non-invasive Ventilation on Rehabilitation Outcome in COPD-patientsNCT01384981 · collaborator · 2011-01-01
TERMINATED
Sleep Apnea Treatment During Cardiac Rehabilitation of Congestive Heart Failure PatientsNCT01120548 · collaborator · 2010-09-01
COMPLETED
Home Mechanical Ventilation vs Home Oxygen Therapy in COPDNCT00990132 · collaborator · 2009-10-01
COMPLETED
Changes in Blood Gases, Disturbance of Breath During Sleep and Cardiovascular Co-morbidity in COPD PatientsNCT00888342 · collaborator · 2009-05-01
COMPLETED
Chronic Heart Failure - Cheyne Stokes Respiration - CS2 (3C-study)NCT00563693 · collaborator · 2007-09-01
COMPLETED

Drugs studied in this sponsor's trials

0 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing ResMed as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

No mapped drug interventions are published for this sponsor's trials. This does not mean the studies contain no drug interventions: some registry names have not been mapped to RxNorm.

Sponsor roles

lead sponsor29
collaborator24
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.